Last reviewed · How we verify

NCT04927234

Foot and Ankle Post-operative Oedema Management Using Geko™

Completed NA Last updated 10 February 2025
What this trial tests

NA trial testing geko™ therapy in Surgery in 123 participants. Completed in 5 August 2024.

Timeline
7 October 2022
Primary endpoint
9 July 2024
5 August 2024

Quick facts

Lead sponsorFirstkind Ltd
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment123
Start date7 October 2022
Primary completion9 July 2024
Estimated completion5 August 2024
Sites5 locations across United Kingdom, United States, Spain

Drugs / interventions tested

Conditions studied

Sponsor

Firstkind Ltd

Who can join

18 and older, any sex, with Surgery or Edema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The multicentre randomised geko™ Foot and Ankle Trial will prospectively and systematically collect clinical data on patients randomised, on a 1:1 basis, to either standard care or standard care plus geko™ therapy to assess oedema management and patient outcomes during a follow-up period of up to three months post-surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Firstkind Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04927234.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing